Yousif Capital Management’s Privia Health PRVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$818K Buy
31,782
+373
+1% +$8.64K 0.01% 1157
2026
Q1
$646K Sell
31,409
-381
-1% -$8.59K 0.01% 1280
2025
Q4
$738K Sell
31,790
-4,175
-12% -$102K 0.01% 1232
2025
Q3
$896K Sell
35,965
-3,722
-9% -$80.1K 0.01% 1159
2025
Q2
$913K Buy
39,687
+955
+2% +$22.1K 0.01% 1173
2025
Q1
$870K Sell
38,732
-982
-2% -$22.8K 0.01% 1176
2024
Q4
$776K Sell
39,714
-679
-2% -$13.5K 0.01% 1287
2024
Q3
$736K Sell
40,393
-1,713
-4% -$32.7K 0.01% 1331
2024
Q2
$732K Sell
42,106
-4,814
-10% -$85.3K 0.01% 1295
2024
Q1
$919K Sell
46,920
-5,708
-11% -$121K 0.01% 1235
2023
Q4
$1.21M Buy
52,628
+563
+1% +$12.6K 0.01% 1125
2023
Q3
$1.2M Buy
52,065
+574
+1% +$14.6K 0.02% 1047
2023
Q2
$1.34M Buy
+51,491
New +$1.36M 0.02% 1001

Other funds holding PRVA

Yousif Capital Management's PRVA Position: Q2 2026 in Review

Yousif Capital Management increased its Privia Health (PRVA) stake by 1.2% in Q2 2026, buying an estimated $8.64K and bringing the position to 31,782 shares worth $818K. The position accounts for 0.01% of the portfolio, ranked #1157.

Yousif Capital Management first reported a position in PRVA in Q2 2023 and has held it in 13 quarters since. The position peaked at $1.34M in Q2 2023. 301 funds tracked by Wall St. Rank hold PRVA as of Q2 2026.

  • Yousif Capital Management held 31,782 shares of Privia Health worth $818K as of Q2 2026.
  • Yousif Capital Management bought 373 Privia Health shares in Q2 2026, an estimated $8.64K.
  • Privia Health made up 0.01% of Yousif Capital Management's portfolio in Q2 2026, its #1157 holding.
  • Yousif Capital Management first reported a position in Privia Health in Q2 2023 and has held it in 13 quarters since.
  • Yousif Capital Management's Privia Health position peaked at $1.34M in Q2 2023.
  • 301 funds tracked by Wall St. Rank held Privia Health as of Q2 2026.

Based on Yousif Capital Management's 13F filing for Q2 2026, filed 16 Jul 2026.